Evidence map›Paper›PMID 27429131›Full record

ArticleHealthcare (Basel, Switzerland)2013

Detection and Discrimination of Non-Melanoma Skin Cancer by Multimodal Imaging.

Sandro Heuke, Nadine Vogler, Tobias Meyer, Denis Akimov, Franziska Kluschke, Hans-Joachim Röwert-Huber, Jürgen Lademann, Benjamin Dietzek, Jürgen Popp

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Non-invasive Imaging Techniques: From Histology to In-vivo Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Advanced Microscopy Techniques.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  4. In vivo and ex vivo sonographic evaluation of tumor margins during micrographic-controlled surgery: a promising new tool in dermato-oncology?Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
  5. Article
  6. Article
  7. Multi-Wavelength Raman Differentiation of Malignant Skin Neoplasms.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Photoacoustic imaging of periorbital skin cancerBiomedical optics express · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sandro HeukeInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. sandro.heuke@ipht-jena.de.
Nadine VoglerInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. nadine.vogler@uni-jena.de.
Tobias MeyerInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. tobias.meyer@ipht-jena.de.
Denis AkimovInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. denis.akimov@ipht-jena.de.
Franziska KluschkeDepartment of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany. Franziska.Kluschke@gmail.com.
Hans-Joachim Röwert-HuberDepartment of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Jürgen LademannDepartment of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany. juergen.lademann@charite.de.
Benjamin DietzekInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. benjamin.dietzek@uni-jena.de.
Jürgen PoppInstitute of Photonic Technology Jena (IPHT), Albert-Einstein-Straße 9, Jena 07745, Germany. rgen.Popp@ipht-jena.de.
Leibniz Institute of Photonic Technology · DECharité - Universitätsmedizin Berlin · DEFriedrich Schiller University Jena · DEHelmholtz Institute Jena · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-melanoma skin cancer (NMSC) belongs to the most frequent human neoplasms. Its exposed location facilitates a fast ambulant treatment. However, in the clinical practice far more lesions are removed than necessary, due to the lack of an efficient pre-operational examination procedure: Standard imaging methods often do not provide a sufficient spatial resolution. The demand for an efficient in vivo imaging technique might be met in the near future by non-linear microscopy. As a first step towards this goal, the appearance of NMSC in various microspectroscopic modalities has to be defined and approaches have to be derived to distinguish healthy skin from NMSC using non-linear optical microscopy. Therefore, in this contribution the appearance of ex vivo NMSC in a combination of coherent anti-Stokes Raman scattering (CARS), second harmonic generation (SHG) and two photon excited fluorescence (TPEF) imaging-referred as multimodal imaging-is described. Analogous to H&E staining, an overview of the distinct appearances and features of basal cell and squamous cell carcinoma in the complementary modalities is derived, and is expected to boost in vivo studies of this promising technological approach.

Indexed as

basal cell carcinomaCARScoherent Raman scatteringmultimodal imagingnon-melanoma skin cancerSHGskin cancersquamous cell carcinomaTPEF

Identifiers

PMID27429131
PMCPMC4934506
OpenAlexW2069305633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.